Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Conditioning Regimen B
- Development stage
- Unknown
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Intravenous, Radiation
01
Overview
Conditioning Regimen B is a pre-transplant conditioning protocol used in allogeneic hematopoietic stem cell transplantation. It comprises Total Body Irradiation (TBI), the antimetabolite fludarabine, and the alkylating agent cyclophosphamide. The regimen is designed to eliminate residual malignant cells and suppress the recipient's immune system to prevent graft rejection.
02
Targets
DNA
Beyond the preview
Go deeper on Conditioning Regimen B.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Conditioning Regimen B.